{
    "Rank": 698,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT04253509",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "2019-11-080"
                },
                "Organization": {
                    "OrgFullName": "Samsung Medical Center",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Liquid Biopsy Using Methylation Sequencing for Lung Cancer",
                "OfficialTitle": "Clinical Utility of Circulating Tumor DNA Methylation in the Diagnosis of Primary Lung Cancer"
            },
            "StatusModule": {
                "StatusVerifiedDate": "February 2022",
                "OverallStatus": "Completed",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "February 3, 2020",
                    "StartDateType": "Actual"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "January 31, 2022",
                    "PrimaryCompletionDateType": "Actual"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "January 31, 2022",
                    "CompletionDateType": "Actual"
                },
                "StudyFirstSubmitDate": "January 31, 2020",
                "StudyFirstSubmitQCDate": "January 31, 2020",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "February 5, 2020",
                    "StudyFirstPostDateType": "Actual"
                },
                "LastUpdateSubmitDate": "February 5, 2022",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "February 8, 2022",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Principal Investigator",
                    "ResponsiblePartyInvestigatorFullName": "Sang-Won Um",
                    "ResponsiblePartyInvestigatorTitle": "Professor",
                    "ResponsiblePartyInvestigatorAffiliation": "Samsung Medical Center"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Samsung Medical Center",
                    "LeadSponsorClass": "OTHER"
                },
                "CollaboratorList": {
                    "Collaborator": [
                        {
                            "CollaboratorName": "EDGC Inc.",
                            "CollaboratorClass": "UNKNOWN"
                        }
                    ]
                }
            },
            "OversightModule": {
                "OversightHasDMC": "No",
                "IsFDARegulatedDrug": "No",
                "IsFDARegulatedDevice": "No"
            },
            "DescriptionModule": {
                "BriefSummary": "This study aims to investigate the utility of circulating tumor DNA (ctDNA) methylation sequencing in the diagnosis of primary lung cancer.",
                "DetailedDescription": "Plasma sample of patients with and without lung cancer will be collected and analyzed using methylation-sensitive enzyme sequencing method. Diagnostic performance of ctDNA methylation sequencing will be compared with that of tumor markers (CEA, Cyfra 21-1, and NSE) combined."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Lung Cancer",
                        "Diagnoses Disease"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "Lung Cancer",
                        "Methylation Sequencing",
                        "Liquid Biopsy"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Observational",
                "PatientRegistry": "No",
                "DesignInfo": {
                    "DesignObservationalModelList": {
                        "DesignObservationalModel": [
                            "Cohort"
                        ]
                    },
                    "DesignTimePerspectiveList": {
                        "DesignTimePerspective": [
                            "Prospective"
                        ]
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "280",
                    "EnrollmentType": "Actual"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "Lung cancer",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Diagnostic Test: Circulating Tumor DNA Methylation Sequencing"
                                ]
                            }
                        },
                        {
                            "ArmGroupLabel": "Benign pulmonary disease",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Diagnostic Test: Circulating Tumor DNA Methylation Sequencing"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Diagnostic Test",
                            "InterventionName": "Circulating Tumor DNA Methylation Sequencing",
                            "InterventionDescription": "Whole blood (21mL) collection through venipuncture. Analysis of tumor markers and ctDNA methylation sequencing.",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Benign pulmonary disease",
                                    "Lung cancer"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Diagnostic sensitivity of ctDNA methylation sequencing",
                            "PrimaryOutcomeDescription": "Using pathologic diagnosis of lung cancer as gold standard, diagnostic sensitivity of ctDNA methylation will be compared with that of tumor markers.",
                            "PrimaryOutcomeTimeFrame": "2 year"
                        },
                        {
                            "PrimaryOutcomeMeasure": "Diagnostic specificity of ctDNA methylation sequencing",
                            "PrimaryOutcomeDescription": "Using pathologic diagnosis of lung cancer as gold standard, diagnostic specificity of ctDNA methylation will be compared with that of tumor markers.",
                            "PrimaryOutcomeTimeFrame": "2 year"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Diagnostic accuracy of ctDNA methylation sequencing",
                            "SecondaryOutcomeDescription": "Using pathologic diagnosis of lung cancer as gold standard, diagnostic accuracy of ctDNA methylation will be compared with that of tumor markers.",
                            "SecondaryOutcomeTimeFrame": "2 year"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Positive predictive value of ctDNA methylation sequencing",
                            "SecondaryOutcomeDescription": "Using pathologic diagnosis of lung cancer as gold standard, positive predictive value of ctDNA methylation will be compared with that of tumor markers.",
                            "SecondaryOutcomeTimeFrame": "2 year"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Negative predictive value of ctDNA methylation sequencing",
                            "SecondaryOutcomeDescription": "Using pathologic diagnosis of lung cancer as gold standard, negative predictive value of ctDNA methylation will be compared with that of tumor markers.",
                            "SecondaryOutcomeTimeFrame": "2 year"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nLung cancer group\n\nPathologically proven lung cancer\nClinically suspected lung cancer on chest CT scan\n\nBenign pulmonary disease group\n\nChronic obstructive pulmonary disease, interstitial lung disease, pneumonia, bronchiectasis, non-tuberculous mycobacterial lung disease, pulmonary vascular disease\n\nExclusion Criteria:\n\nPatients with previous history of lung cancer\nPatients who have been diagnosed with other malignancy within 5 years\nUnstable vital status\nActive pulmonary tuberculosis\nInfection with hepatitis B virus (HBV), hepatitis C virus (HCV), or human immunodeficiency virus (HIV)",
                "HealthyVolunteers": "No",
                "Gender": "All",
                "MinimumAge": "15 Years",
                "MaximumAge": "85 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Child",
                        "Adult",
                        "Older Adult"
                    ]
                },
                "StudyPopulation": "Lung cancer\n\nPathologically proven lung cancer\n\nClinically suspected lung cancer on chest CT scan\n\nnodule, mass, pulmonary infiltrate, or consolidation\nsize : diameter at least 1 cm\nCT attenuation of solid or part-solid\nplanned to follow-up, biopsy, or surgical resection\n\nBenign pulmonary disease\n\nCOPD : post bronchodilator FEV1/FVC < 0.7 and FEV1 pred < 80%\nILD : either histologic or clinical diagnosis\nPneumonia : community or hospital acquired\nBronchiectasis : chest CT diagnosis\nNTM : at least 2 isolation of pathogen from sputum\nPulmonary vascular disease : embolism, pulmonary hypertension, arteriovenous malformation",
                "SamplingMethod": "Non-Probability Sample"
            },
            "ContactsLocationsModule": {
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Sang-Won Um, MD, PhD",
                            "OverallOfficialAffiliation": "Samsung Medical Center",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Samsung Medical Center",
                            "LocationCity": "Seoul",
                            "LocationCountry": "Korea, Republic of"
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000008175",
                            "ConditionMeshTerm": "Lung Neoplasms"
                        },
                        {
                            "ConditionMeshId": "D000004194",
                            "ConditionMeshTerm": "Disease"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000012142",
                            "ConditionAncestorTerm": "Respiratory Tract Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000013899",
                            "ConditionAncestorTerm": "Thoracic Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000008171",
                            "ConditionAncestorTerm": "Lung Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000012140",
                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000010335",
                            "ConditionAncestorTerm": "Pathologic Processes"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M10862",
                            "ConditionBrowseLeafName": "Lung Neoplasms",
                            "ConditionBrowseLeafAsFound": "Lung Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M14669",
                            "ConditionBrowseLeafName": "Respiratory Tract Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M16348",
                            "ConditionBrowseLeafName": "Thoracic Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M10858",
                            "ConditionBrowseLeafName": "Lung Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M14667",
                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC08",
                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        }
                    ]
                }
            }
        }
    }
}